BREWIN DOLPHIN LTD - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 103 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2019. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2019$22,240
-14.3%
3,200
-28.0%
0.00%
-33.3%
Q4 2018$25,965
-22.6%
4,4460.0%0.00%
-25.0%
Q3 2018$33,567
+49.5%
4,4460.0%0.00%
+33.3%
Q2 2018$22,4524,4460.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$3,107,0001.71%
ETF MANAGERS GROUP, LLC 14,138,998$8,534,0000.17%
Ikarian Capital, LLC 948,526$584,0000.09%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 318,668$196,0000.03%
Platform Technology Partners 45,000$28,0000.01%
XTX Topco Ltd 34,476$21,0000.01%
PINNACLE ASSOCIATES LTD 947,083$583,0000.01%
Penserra Capital Management LLC 537,236$330,0000.01%
Mirae Asset Global Investments Co., Ltd. 4,070,006$2,506,0000.01%
Tekla Capital Management LLC 154,310$95,0000.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders